The U.S. Food and Drug Administration (FDA) initiated plans to remove concentrated ingestible fluoride prescription drugs marketed for children on Tuesday, noting their impact on gut health.

The Food and Drug Administration has been meeting with OpenAI to discuss the agency’s use of AI, according to sources with knowledge of the meetings. The meetings appear to be part of a broader ...